AMERICAN ASSOCIATION FOR CANCER RESEARCH

Lobbying for AMERICAN ASSOCIATION FOR CANCER RESEARCH

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 16, 2026

Expenses

$100,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 4

Budget/Appropriations

FY 2026 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.

Medical/Disease Research/Clinical Labs

Cancer research generally Diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention

Tobacco

Tobacco control and prevention Tobacco cessation

Health Issues

Reducing cancer disparities Cancer survivorship Preventing HPV-related cancers

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.